Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
- 16 November 2024
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 400, 119054
Abstract
No abstract availableKeywords
Funding Information
- French National Research Agency (ANR-23-CE14-0091, 18-CE15-0024-03 NASHILCCD8, ANR-10-LABX-0046, 16-RHUS-0006)
- HORIZON EUROPE European Research Council
This publication has 92 references indexed in Scilit:
- TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular DiseaseHepatology Communications, 2021
- Role of Cholesterol‐Associated Steatohepatitis in the Development of NASHHepatology Communications, 2021
- Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic SteatohepatitisObesity, 2019
- Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver diseaseHepatology, 2017
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015
- Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acidsHepatology, 2015
- Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* studyHepatology, 2014
- A lipidomic analysis of nonalcoholic fatty liver diseaseHepatology, 2007
- Alterations in Liver ATP Homeostasis in Human Nonalcoholic SteatohepatitisJAMA, 1999